Not only does our work help provide insights into the mechanism(s) of LAMA4 upregulation and its association with advanced pancreatic cancer, it also holds the promise of yielding potential biomarker(s) and therapeutic targets for an improved management of pancreatic cancer. This evidence concerns the gene LAMA4 and familial pancreatic carcinoma.